SB 319-FN (2024): relative to vaccine and pharmaceutical products purchased, promoted, or distributed by the state and its political subdivisions.

Cite this page

Granite Record indexes the General Court’s record; it is not that record. Where a citation allows only one source, cite the General Court — every page here links to what it is drawn from. The date below is the day the page was read.

MLA
“SB 319-FN (2024): relative to vaccine and pharmaceutical products purchased, promoted, or distributed by the state and its political subdivisions.” Granite Record, https://graniterecord.org/bill/2024/sb319. Accessed 24 Oct. 2026.
APA
Granite Record. (n.d.). SB 319-FN (2024): relative to vaccine and pharmaceutical products purchased, promoted, or distributed by the state and its political subdivisions. Retrieved 24 Oct. 2026, from https://graniterecord.org/bill/2024/sb319
Chicago
Granite Record. “SB 319-FN (2024): relative to vaccine and pharmaceutical products purchased, promoted, or distributed by the state and its political subdivisions.” Accessed 24 Oct. 2026. https://graniterecord.org/bill/2024/sb319.
BibTeX
@misc{bill-2024-sb319, title = {SB 319-FN (2024): relative to vaccine and pharmaceutical products purchased, promoted, or distributed by the state and its political subdivisions.}, howpublished = {Granite Record}, url = {https://graniterecord.org/bill/2024/sb319}, note = {Accessed 24 Oct. 2026} }

SB 319-FN (2024)

relative to vaccine and pharmaceutical products purchased, promoted, or distributed by the state and its political subdivisions.

  • Status: Referred for interim study
  • Term: 2023-2024
  • Senate committee: Health and Human Services
  • Subject: Public and Mental Health

The Story

It was introduced on January 3, 2024 and referred to the Senate Health and Human Services committee. The committee held a public hearing on January 10, 2024. The committee voted 4–1 to recommend that the Senate study it after the session ends. On February 8, 2024 the Senate adopted “Refer to Interim Study” on a voice vote.

Sponsors

Hearings and Sessions

  • January 10, 2024, 1:00 PM: hearing, Senate Health and Human Services, LOB 101

Votes

  • February 8, 2024, Senate: Refer to Interim Study — voice vote, passed

The Docket

  • January 3, 2024: To Be Introduced 01/03/2024 and Referred to Health and Human Services
  • January 10, 2024: Hearing: 01/10/2024, Room 101, LOB, 01:00 pm
  • February 8, 2024: Committee Report: Referred to Interim Study, 02/08/2024, Vote 4-1
  • February 8, 2024: Refer to Interim Study, MA, VV; 02/08/2024

Laws It Would Change

Related Bills

  • HB 575-FN (2023): relative to vaccine and pharmaceutical products purchased, promoted, or distributed by the state and its political subdivisions.

From the General Court